---
title: "雅迪控股：德勤获委任为新任核数师"
description: "智通财经 APP 讯，雅迪控股发布公告，根据审核委员会的推荐建议，德勤已获委任为本公司的新任核数师，自 2025 年 9 月 22 日起生效，以填补罗兵咸永道辞任后的临时空缺，并任职至下届本公司股东周年大会结束为止。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/258329836.md"
published_at: "2025-09-22T10:39:05.000Z"
---

# 雅迪控股：德勤获委任为新任核数师

> 智通财经 APP 讯，雅迪控股发布公告，根据审核委员会的推荐建议，德勤已获委任为本公司的新任核数师，自 2025 年 9 月 22 日起生效，以填补罗兵咸永道辞任后的临时空缺，并任职至下届本公司股东周年大会结束为止。

智通财经 APP 讯，雅迪控股 (01585) 发布公告，根据审核委员会的推荐建议，德勤已获委任为本公司的新任核数师，自 2025 年 9 月 22 日起生效，以填补罗兵咸永道辞任后的临时空缺，并任职至下届本公司股东周年大会结束为止。

### Related Stocks

- [01585.HK - 雅迪控股](https://longbridge.com/zh-CN/quote/01585.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yadea Group Holdings Ltd. (1585) Gets a Buy from Huatai Securities | Huatai Securities analyst maintained a Buy rating on Yadea Group Holdings Ltd. yesterday and set a price target of HK$18 | [Link](https://longbridge.com/zh-CN/news/271879979.md) |
| Yadea Group Holdings Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025 | Yadea Group Holdings Ltd. provided consolidated earnings guidance for the year ended 31 December 2025. For the period, t | [Link](https://longbridge.com/zh-CN/news/271638796.md) |
| Novautek Technologies expects loss of HK$30.5 million for HY | Novautek Technologies expects loss of HK$30.5 million for HY | [Link](https://longbridge.com/zh-CN/news/275923659.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/zh-CN/news/276016059.md) |
| Sino Harbour Chairman Boosts Stake with Open-Market Share Purchase | Sino Harbour Holdings Group Limited's chairman, Wong Lam Ping, has increased his stake by purchasing 8,644,000 shares at | [Link](https://longbridge.com/zh-CN/news/275769398.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。